Morgan Stanley Downgrades DENTSPLY International (XRAY) to Equalweight

(updated to add analyst comment)

Morgan Stanley downgraded DENTSPLY International (NASDAQ: XRAY) from Overweight to Equalweight with a price target of $40.00 (from $54.00).

Analyst Steven Beuchaw steps to the sidelines citing limited visibility and persistent cash flow declines.

For an analyst ratings summary and ratings history on DENTSPLY International click here. For more ratings news on DENTSPLY International click here.

Shares of DENTSPLY International closed at $39.41 yesterday.

You May Also Be Interested In

• Morgan Stanley Resumes OMV AG (OMV:AV) (OMVKY) at Equalweight
• JPMorgan Starts Kanzhun Ltd (2076:HK) at Overweight
• Persistent Systems Ltd. (PSYS:IN) PT Lowered to INR5,540 at BNP Paribas Exane